Patent · US Active

Compositions comprising a norovirus nucleic acid and methods of use thereof

US12168050B2 · kind B2 · utility

0Cited by
92References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 8, 2021
Grant dateDec 17, 2024
Priority date
Expiry dateJan 12, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2770/16034
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to an artificial nucleic acid and to polypeptides suitable for use in treatment or prophylaxis of an infection with Norovirus or a disorder related to such an infection. In particular, the present invention concerns a Norovirus vaccine. The present invention is directed to an artificial nucleic acid, polypeptides, compositions and vaccines comprising the artificial nucleic acid or the polypeptides. The invention further concerns a method of treating or preventing a disorder or a disease, first and second medical uses of the artificial nucleic acid, polypeptides, compositions and vaccines. Further, the invention is directed to a kit, particularly to a kit of parts, comprising the artificial nucleic acid, polypeptides, compositions and vaccines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.